| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |